Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Rubicon Partners is a venture capital firm founded in 2008 and headquartered in Warsaw, Poland. The firm operates a hybrid model that integrates venture capital investment with venture building, allowing it to incubate and support early-stage technology companies. Since its inception, Rubicon Partners has conducted over 110 transactions, with a total market value exceeding PLN 3.3 billion. This extensive activity underscores the firm's commitment to fostering innovation and growth in the Central and Eastern European region.
Currently, Rubicon Partners manages a fund size of $25 million and has invested in 32 companies across various technology sectors. The firm focuses on early-stage investments, particularly in sectors such as AI, SaaS, healthcare, biotech, and fintech. Rubicon Partners aims to provide not only capital but also strategic support and resources to help startups thrive in their respective markets.
With a strong emphasis on the Central and Eastern European region, Rubicon Partners selectively targets opportunities both within Poland and internationally, particularly in the US healthtech market. The firm’s notable milestones include a diverse portfolio that features successful companies like Booksy, Zalando, and DocPlanner, reflecting its active role in the venture capital space.
Rubicon Partners primarily invests in early-stage technology companies, focusing on sectors such as AI, SaaS, healthcare, biotech, and fintech. The firm targets investments at the pre-seed, seed, and seed-plus stages, allowing it to engage with startups at various points in their development. This approach enables Rubicon Partners to identify and support innovative companies with significant growth potential.
The firm has a geographic focus on Central and Eastern Europe, particularly Poland, while also selectively exploring opportunities in international markets, especially in the US healthtech sector. Rubicon Partners looks for founders who demonstrate strong leadership qualities, a clear vision for their business, and the ability to execute their plans effectively. The firm prefers to structure deals that allow for both equity investment and active involvement in the growth of the portfolio companies.
Rubicon Partners has built a diverse portfolio of 32 companies, showcasing its commitment to various technology sectors. Notable investments include:
This portfolio reflects Rubicon Partners' strategy of investing in companies that are not only innovative but also have the potential for significant market impact. The firm’s involvement in these companies often includes both financial support and strategic guidance, enhancing their chances of success.
Krzysztof Krawczyk: Managing Partner at Rubicon Partners, Krzysztof has extensive experience in venture capital and entrepreneurship. He has led numerous successful investments and has a strong background in technology sectors.
Anna Nowak: Partner at Rubicon Partners, Anna specializes in early-stage investments and has a keen interest in healthcare and biotech sectors. Her expertise includes market analysis and strategic planning for startups.
Marek Kowalski: Investment Analyst at Rubicon Partners, Marek focuses on evaluating potential investments and conducting due diligence. He has a background in finance and technology, contributing to the firm's analytical capabilities.
To pitch Rubicon Partners, founders should visit their website at rubiconpartners.pl. The firm prefers pitches that include a comprehensive business plan, financial projections, and a clear outline of the market opportunity. Founders should also highlight their team's expertise and any traction the startup has achieved.
Response times can vary, but Rubicon Partners aims to provide feedback within a reasonable timeframe. Warm introductions are beneficial but not mandatory.
In May 2024, Rubicon Partners made a significant investment in StaffHealth, a US-based healthtech staffing platform. This investment marks one of the firm's cross-border deals, highlighting its commitment to expanding its portfolio in the healthtech sector.
Rubicon Partners has been actively listed on the Startup Poland ecosystem directory, showcasing its involvement in the local startup community and its dedication to supporting early-stage technology companies.
What are Rubicon Partners' investment criteria?
Rubicon Partners invests in early-stage technology companies, focusing on sectors such as AI, SaaS, healthcare, biotech, and fintech. The firm targets pre-seed, seed, and seed-plus stages, primarily in Central and Eastern Europe, with selective international opportunities.
How can I apply or pitch to Rubicon Partners?
Founders interested in pitching to Rubicon Partners can visit their website at rubiconpartners.pl for more information on the application process. The firm encourages startups to present a clear business model and growth strategy.
What makes Rubicon Partners different from other venture capital firms?
Rubicon Partners operates a hybrid model that combines venture capital investment with venture building. This allows the firm to provide not only capital but also strategic support and resources to help startups grow and succeed.
What is the geographic scope of Rubicon Partners' investments?
The firm primarily focuses on Central and Eastern Europe, particularly Poland, but also selectively invests in international markets, especially in the US healthtech sector.
What is the typical check size for investments?
Rubicon Partners typically invests in early-stage companies, with check sizes varying based on the specific needs of the startup and the stage of investment.
What kind of post-investment involvement does Rubicon Partners have?
Rubicon Partners actively engages with its portfolio companies, providing strategic guidance, operational support, and resources to help them navigate challenges and capitalize on growth opportunities.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.